Cargando…
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
[Image: see text] Chemogenetic tools such as designer receptors exclusively activated by designer drugs (DREADDs) are routinely used to modulate neuronal and non-neuronal signaling and activity in a relatively noninvasive manner. The first generation of DREADDs were templated from the human muscarin...
Autores principales: | Thompson, Karen J., Khajehali, Elham, Bradley, Sophie J., Navarrete, Jovana S., Huang, Xi Ping, Slocum, Samuel, Jin, Jian, Liu, Jing, Xiong, Yan, Olsen, Reid H. J., Diberto, Jeffrey F., Boyt, Kristen M., Pina, Melanie M., Pati, Dipanwita, Molloy, Colin, Bundgaard, Christoffer, Sexton, Patrick M., Kash, Thomas L., Krashes, Michael J., Christopoulos, Arthur, Roth, Bryan L., Tobin, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407913/ https://www.ncbi.nlm.nih.gov/pubmed/30868140 http://dx.doi.org/10.1021/acsptsci.8b00012 |
Ejemplares similares
-
Validation of DREADD agonists and administration route in a murine model of sleep enhancement
por: Ferrari, Loris L., et al.
Publicado: (2022) -
The Use of DREADDs to Deconstruct Behavior
por: Whissell, Paul D., et al.
Publicado: (2016) -
Eye-Drops for Activation of DREADDs
por: Keenan, William T., et al.
Publicado: (2017) -
Using DREADDs to Isolate Internal Clocks
por: Farrell, Martilias S.
Publicado: (2011) -
Chronic DREADD Isn’t As Bad As It Sounds
por: Hyder, Safwan K., et al.
Publicado: (2020)